Pierre v. Sunrise Med. Labs.

2025 NY Slip Op 50464(U)
CourtNew York Supreme Court, Kings County
DecidedApril 8, 2025
DocketIndex No. 502304/2013
StatusUnpublished
Cited by1 cases

This text of 2025 NY Slip Op 50464(U) (Pierre v. Sunrise Med. Labs.) is published on Counsel Stack Legal Research, covering New York Supreme Court, Kings County primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pierre v. Sunrise Med. Labs., 2025 NY Slip Op 50464(U) (N.Y. Super. Ct. 2025).

Opinion

Pierre v Sunrise Med. Labs. (2025 NY Slip Op 50464(U)) [*1]
Pierre v Sunrise Med. Labs.
2025 NY Slip Op 50464(U)
Decided on April 8, 2025
Supreme Court, Kings County
Mallafre Melendez, J.
Published by New York State Law Reporting Bureau pursuant to Judiciary Law § 431.
This opinion is uncorrected and will not be published in the printed Official Reports.


Decided on April 8, 2025
Supreme Court, Kings County


Madiou Pierre, as Administrator of the Estate of CLOTILDE PIERRE, Plaintiff,

against

Sunrise Medical Laboratories, NING CAI, M.D., GOLDA SIMPSON, CT (ASCP), ELISABETH CAPPELLO, CT (ASCP), JOHN LoFRANCO, CT (ASCP), ELLEN J. ARKIN, CT (ASCP), SANDRA ABO, CT (ASCP), PETER HOLDEN, M.D., JOHN DOE 1 through JOHN DOE 20 and JANE DOE 1 through JANE DOE 20 (the names being fictitious and presently unknown to plaintiff, but intended to be doctors, technicians and/or other persons who reviewed CLOTILDE PIERRE's pathology slides, Defendants.




Index No. 502304/2013

Plaintiff
Seth D. Bader, Esq. (sbader@baderlawfirm.com)
Bloomberg, Steinberg & Bader
521 Fifth Avenue, Fl 30
New York, NY 10175
212-233-6255

Defendants Sunrise Medical Laboratories, Golda Simpson, CT, Elisabeth Cappello, CT, John Lofranco, CT, Ellen J. Arkin, CT, and Sandra Abo, CT
Therea Scotto-Lavino, Esq. (tslavino@lewisjohs.com)
Lewis Johs Avallone Aviles, LLP
61 Broadway
New York, NY 10006-2701
212-233-7195

Defendant Ning Cai, M.D.
Charles J. Adams, Esq. (courts@pfapc.com)
Patrick F. Adams PC
3500 Sunrise Highway, Building 300
Great River, NY 11739
631-666-6200

Defendant Peter Holden, M.D.
Jordan Courtney Conger, Esq. (jcconger@arfdlaw.com)
Aaronson Rappaport Feinstein & Deutsch, LLP
600 Third Avenue New York, NY 10016
212-593-6792
Consuelo Mallafre Melendez, J.

Recitation, as required by CPLR §2219 [a], of the papers considered in the review:

NYSCEF #s: 259 — 261, 262 — 270, 271, 272 — 273, 274 — 279

Plaintiff moves (Seq. No. 11) for an Order, pursuant to CPLR 5019 (a), to "correct and resettle" a prior decision and order signed on January 27, 2021 by the Hon. Bernard J. Graham in this action, and to restore this action to the trial calendar.

Defendants Sunrise Medical Laboratories ("Sunrise Labs"), Golda Simpson, CT ("Simpson"), Elizabeth Cappello, CT ("Cappello"), John Lofranco, CT ("Lofranco"), Ellen J. Arkin, CT ("Arkin"), and Sandra Abo, CT ("Abo") oppose the motion.

This action was first commenced by Plaintiff on May 2, 2013, asserting medical malpractice and wrongful death claims against the movants and others. The Note of Issue was filed on December 21, 2016. All defendants moved for summary judgment.

Plaintiff filed a so-ordered stipulation of discontinuance dated August 18, 2017, which discontinued this action and/or individual claims against multiple defendants, including Sunrise Labs, Cappello, Lofranco, Arkin, and Abo (see NYSCEF Doc. 246). Per the stipulation, two pending summary judgment motions (Seq. No. 8 & 9) were marked withdrawn on August 18, 2017. The withdrawn motions were on behalf of Sunrise Labs, Cappello, Lofranco, Arkin, Abo, Golda Simpson, CT, and Ning Cai, M.D.

The action was then automatically stayed beginning in September 2017, pursuant to bankruptcy proceedings of defendant Peter Holden, M.D.'s ("Dr. Holden") insurer. The stay was lifted in January 2020.

Dr. Holden's motion for summary judgment (Seq. No. 10) was decided on January 27, 2021 by Justice Bernard Graham. In a footnote, the decision stated that "Plaintiff discontinued, with prejudice, all claims against defendants, other than the movant, on August 18, 2017 by a so-ordered stipulation of discontinuance." The decision and order granted summary judgment to Dr. Holden on the merits and concluded that Dr. Holden's motion was "granted in its entirety, and the action is dismissed." This decision and order was entered in NYSCEF on February 3, 2021. Plaintiff did not appeal this Order, nor did they move to re-argue the decision.

Now, Plaintiff filed a motion on January 29, 2025 to resettle and correct a "mistake, defect, or irregularity" in the 2021 decision and order, to the extent the decision stated all defendants other than Dr. Holden were discontinued and the action was dismissed in its entirety. Plaintiff contends that pursuant to the August 2017 Stipulation, some claims against Sunrise Labs, Cappello, Lofranco, Arkin, and Abo remained active, and that the Court made a mistake in the footnote by misinterpreting the Stipulation. They argue that the mistake can be corrected pursuant to CPLR 5019 (a), and that the Order should be resettled and the action restored to the calendar as to those defendants.

In opposition, the defendants argue that this motion to modify the previous order and restore the [*2]action to the calendar is untimely, made four years after the action was disposed. They also argue that the remedy sought affects their substantial rights, precluding the use of CPLR 5019 (a).

Plaintiff refers to this motion as an application to "resettle" the prior order or judgment. Pursuant to CPLR 5019, "trial and appellate courts have the discretion to cure mistakes, defects and irregularities that do not affect substantial rights of parties" (Kiker v Nassau County, 85 NY2d 876 [1995]). This relief may be sought at any time to correct a clerical mistake or defect, such as to align a judgment more accurately with the intention of the parties and the court (see Ayrovainen v Ayrovainen, 94 AD3d 922, 922 [2d Dept 2012]). However, "(a) motion for resettlement is designed not for substantive changes, but to correct errors or omissions in form, for clarification or to make the order conform more accurately to the decision" (Simon v Mehryari, 16 AD3d 664, 666 [2d Dept 2005]). "Resettlement is generally intended to remedy clerical errors or clear mistakes in an order or judgment when there is no dispute about the substance of what that order or judgment should contain. It may be used where the order improperly reflects the decision or fails to include necessary recitals, but cannot be used to obtain a ruling not adjudicated on the original motion or to modify the decision which has been made." (Joseph v Baksh, 137 AD3d 1220, 1221 [2d Dept 2016], citing Simon, 16 AD3d 664 [emphasis added]).

It is well established that resettlement is not an appropriate remedy where it constitutes "a substantive change" in the judgment (Renaud v Renaud, 197 AD3d 515, 517 [2d Dept 2021]). Judicial errors in a "matter of substance" must be "corrected either by the vacating of the judgment or by an appeal" (Herpe v Herpe, 225 NY 323, 327 [1919]). The Second Department has more recently clarified that CPLR 5019 (a) is "a quiet and infrequently used statute" meant to "correct minor mistakes, defects, or irregularities" (Sokoloff v Schor, 176 AD3d 120, 130 [2d Dept 2019]). "When properly utilized, the statute . . operates as a safety net for jurists to correct clerical type errors . . . such as mathematical errors in calculations.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pierre v. Sunrise Med. Labs.
2025 NY Slip Op 50464(U) (New York Supreme Court, Kings County, 2025)

Cite This Page — Counsel Stack

Bluebook (online)
2025 NY Slip Op 50464(U), Counsel Stack Legal Research, https://law.counselstack.com/opinion/pierre-v-sunrise-med-labs-nysupctkings-2025.